Improving oligodendroglial differentiation from human foetal neural progenitor cells remains a primordial issue to accomplish successful cell-based therapies in myelin diseases. Here, we combined in situ, in vitro and in vivo approaches to assess the oligodendrogenic potential of different human foetal forebrain regions during the first trimester of gestation. We show for the first time that the initial wave of oligodendrocyte progenitor emergence in the ventral telencephalon onsets as early as 7.5 weeks into gestation. Interestingly, in vitro, isolation of ganglionic eminences yielded oligodendrocyte progenitor-enriched cultures, as compared with cortex and thalamus. Most importantly, single injection of human neural progenitors into rodent models of focal gliotoxic demyelination revealed the great capacity of these cells to survive, extensively migrate and successfully remyelinate the spinal cord, irrespective of their origin. Thus, our study brings novel insights into the biology of early human foetal neural progenitor cells and offers new support for the development of cellular therapeutics for myelin disorders.
Introduction
Neural stem cells are a promising tool for cell replacement in various neurological disorders, including diseases that manifest with myelin failure or loss, such as multiple sclerosis or some leucodystrophies. The proliferative properties of these cells, as well as their ability to generate the major cell types of the CNS, including myelinating oligodendrocytes, have enabled the validation of their regenerative potential in a variety of demyelinating models (Chandran et al., 2008; Duncan, 2008; Goldman et al., 2008; Tepavcevic and Baron-Van Evercooren, 2008; Martino et al., 2010) .
However, the difficulty to derive and amplify human oligodendrocyte progenitor cells from immature neural stem/progenitor cells (Quinn et al., 1999; Roy et al., 1999; Zhang et al., 2000; Buchet et al., 2002a; Chandran et al., 2004) , especially when isolated during early foetal development, has long hampered successful remyelination attempts in these models ). This limitation was due, at least in part, to the fact that protocols of epigenetic stimulation known to promote rodent neural stem cell commitment towards the oligodendroglial lineage have proven inefficient in humans (Murray and Dubois-Dalcq, 1997; Zhang et al., 2000) . As a result, various strategies have been explored to enhance the myelinating potential of neural stem and progenitor cells. One of these consisted of selecting early glial progenitor cells from human tissue, based on their expression of membrane markers (Roy et al., 1999; Windrem et al., 2004 Windrem et al., , 2008 . Thus, A2B5 + / PSA-NCAM À progenitors isolated from second trimester foetal neural tissue were shown to extensively myelinate the congenitally dysmyelinated CNS of newborn myelin basic protein (MBP)-deficient 'shiverer' mice, as well as to re-establish normal axonal conduction and prolong the otherwise shortened life-span of the animals . Recently, another strategy was developed that consisted of promoting the commitment of human foetal neural progenitor cells (hNPCs) towards the oligodendroglial lineage by genetic stimulation (Maire et al., 2009) . Over-expression of the transcription factor Olig2 induced oligodendrocyte progenitor cell specification from transduced hNPCs in vitro, and a 2-fold increase in oligodendroglial differentiation after grafting into 'shiverer' mouse brain. A third strategy would consist of defining a CNS region that may be enriched in putative oligodendrocyte progenitor cells during early foetal development.
In the present work, we focused on this latter strategy and evaluated the oligodendroglial potential of foetal hNPCs isolated from different parts of the forebrain during the first trimester of gestation.
In rodents, the sequence of forebrain oligodendrocyte progenitor cell specification has been well described (Spassky et al., 1998; Kessaris et al., 2006) . A first wave of oligodendrocyte progenitor cell emergence takes place around embryonic Day 12.5 in the medial ganglionic eminences and entopeduncular area (Spassky et al., 1998) . By that time, most oligodendrocyte progenitor cells are concentrated in well-defined parts of the ventral forebrain and have not yet dispersed throughout lateral and dorsal areas. A second wave of oligodendrocyte progenitor cell emergence takes place around embryonic Day 15 in the lateral ganglionic eminences, followed by a third wave that appears dorsally in the cortex after birth. Each of these waves give rise to distinct oligodendrocyte progenitor cell populations that can be distinguished from one another by the initial expression of homeobox genes that sign their territorial origins . However, the functional homology between these oligodendrocyte progenitor cell populations is still a matter of debate .
In humans, numerous similarities were highlighted with rodent forebrain development. In particular, colocalization of early oligodendrocyte progenitor cell markers with homeobox genes suggested that, as in rodents, human oligodendrocytes originate from at least three distinct areas of the forebrain, including the medial and lateral ganglionic eminences and cortical ventricular zone (Rakic and Zecevic, 2003) . However, until now, most of the developmental studies focusing on oligodendrocyte progenitor cell emergence in the human forebrain have been conducted either at very early stages of development when oligodendrocyte progenitor cells cannot yet be detected (Jakovcevski and Zecevic, 2005a) , or on second trimester foetuses, between 15 and 23 weeks of gestation, by which time oligodendrocyte progenitor cells have already colonized ventral and dorsal territories (Back et al., 2001; Rakic and Zecevic, 2003; Jakovcevski and Zecevic, 2005a, b; Jakovcevski et al., 2009) . Thus, there appears to be a gap in brain development description during the first trimester of gestation, and the switch from neurogenesis to oligodendrogenesis that takes place around embryonic Day 12.5 in the rodent forebrain has not yet been well dated in humans.
Understanding the time course of oligodendrocyte emergence within the human developing brain, as well as the events leading to oligodendrocyte differentiation and myelination, remains a key issue for successful therapies. In the present study, we combined multiple approaches to assess the oligodendrogenic potential of different human forebrain regions. Reverse transcriptionpolymerase chain reaction and immunohistochemical analysis performed on human foetal brain tissue allowed for the characterization of the spatio-temporal onset of oligodendrogenesis during early human gestation. Moreover, isolation of cells from cortex, ganglionic eminences and thalamus allowed enrichment of putative early oligodendrocyte progenitor cells in vitro. Finally, we demonstrated that, after amplification, hNPCs from these three regions displayed great propensities to survive, migrate and generate large amounts of myelinating oligodendrocytes when grafted into two different mouse models of spinal cord focal demyelination.
Materials and methods

Tissues
Human foetuses were obtained after legal abortion according to the recommendations of the Agence de la Biomedecine (agreement #003187) with the written consent of the patients. The samples were aged as follows: 6.5 (n = 1), 7.5 (n = 2), 8.5 (n = 2) and 9 (n = 1) weeks of gestation as determined by crown-to-rump length measurement by ultrasound scanning and by observation of development of the fingers and toes. The collection procedure was performed as previously described (Buc-Caron, 1995 Dulbecco's modiEed Eagle's medium-F12 (Invitrogen) supplemented with 1% N2 supplement (Invitrogen); 0.5% B27 (Invitrogen); 25 mg/ ml insulin (Sigma-Aldrich); 6 mg/ml glucose (Sigma-Aldrich); 5 mM HEPES (Invitrogen); 20 ng/ml basic fibroblast growth factor (SigmaAldrich) and 20 ng/ml epidermal growth factor (Sigma-Aldrich)]. After 5 days, cells were fixed in 4% paraformaldehyde (SigmaAldrich).
Amplification
Dissociated cells from the cortex, ganglionic eminences and thalamus were seeded at the density of 10 6 cells/T75 flask in 10 ml NEF medium. Fresh medium was added twice a week. Long-term amplification was performed by successive passages every 2-3 weeks, depending on the size of the spheres and growth rate of each region. At each passage, spheres from each region were dissociated in ATV and re-seeded at the density of 10 6 cells/T75 flask in 10 ml NEF medium.
Long-term characterization
Cells were amplified as described above for 100 days in vitro (P8-P9), dissociated in ATV, seeded in 24-well plates (5 Â 10 4 cells/well) and further processed as for short-term characterization.
Demyelination and transplantation Demyelination and transplantation in nude mice
Adult Swiss nude mice (8-10 weeks of age; Janvier) were anaesthetized by intraperitoneal injection of a mixture of 150 mg/kg ketamine (Alcyon) and 150 mg/kg xylazine (Alcyon). Focal demyelination was performed in 48 animals by single injection of 1 ml of 1% lysolecithin (Sigma-Aldrich) into the dorsal funiculus of the spinal cord of each animal at the level of the 13th thoracic vertebrae. Forty-eight hours after lysolecithin injection, 1 ml of cell suspension (10 5 cells/ml) from cortex, ganglionic eminences and thalamus was injected at the site of demyelination. Transplantation studies were performed with hNPCs from two independent foetuses. Twenty-four animals were used for each foetus, divided into three groups of eight animals for each region (cortex, ganglionic eminences and thalamus). Cells were injected after amplification and transduction with the cytomegalovirus-green fluorescent protein (CMV-GFP) lentiviral vector.
Mice were sacrificed at 6 (n = 6 per group) and 33-49 weeks postgrafting (n = 2 per group) by transcardiac perfusion of 0.9% NaCl (Merck) and 4% paraformaldehyde. After dissection, spinal cords were cryopreserved in 15% sucrose-1 Â phosphate buffered saline overnight. They were then included in 7% gelatin (Merck)-15% sucrose (Sigma-Aldrich)-1 Â phosphate buffered saline, frozen in cold isopenthane at -60 C and stored at -80 C until use. Thick sections of 12 mm were cut with a cryostat (Leica) and used for immunohistochemistry.
Demyelination and transplantation in 'shiverer' mice
Adult 'shiverer' mice (BalbC strain; 8 weeks of age) were demyelinated and transplanted following the same procedure as described above. For this series of experiments, 0.5 ml of cell suspension (10 5 cells/ml) from cortex, ganglionic eminences and thalamus were grafted after amplification in vitro (n = 10 per region), but without previous lentiviral transduction. Mice were immunosuppressed by daily injection of 20 mg/kg cyclosporine A (Sandimmun) and sacrificed at 10.5 weeks post-grafting. For immunohistochemistry, tissues were processed as described above (n = 4 per group and per region). For electron microscopy, mice were perfused with 0.9% NaCl followed by a mixture of 4% paraformaldehyde/2.5% glutaraldehyde (Electron Microscopy Science) in 1Â phosphate buffered saline for 45 min (n = 4 per group and per region).
Immunochemistry Immunocytochemistry
Human cell characterization was performed using the following primary antibodies: anti-human Nestin (1:1000; clone Nestin 24, Covance); anti-Olig2 (1:500, Chemicon AB9610); anti-b3-tubulin (1:800, Sigma-Aldrich); anti-MAP5 (1:200, clone AA6, SigmaAldrich); A2B5 (1:5 mouse IgM hybridoma from ATCC); O4 (1:5, mouse IgM hybridoma from ATCC) and anti-glial fibrillary acidic protein (GFAP; 1:500, Dako). Cells were then incubated for 10 min in Hoechst dye (1 mg/ml Sigma-Aldrich) and with the corresponding secondary antibodies.
Immunohistochemistry
Human cells transplanted in nude mice were identified according to their native expression of GFP, or with an antibody directed against GFP (1:500, Interchim). 
Electron microscopy
After dissection and post-fixation in 4% paraformaldehyde/2.5% glutaraldehyde, 'shiverer' spinal cords were cut in 0.5-1 mm-thick pieces and fixed in 2% osmium tetroxide (Sigma-Aldrich) overnight. After dehydration, samples were embedded in Epon. Ultra-thin sections (80 nm) were examined with a Philips electron microscope.
Statistical analysis
ANOVA analysis was performed among the three regions using the Sigma Stat software. Pairwise comparison was performed using the Dunn's Method.
The methods for reverse transcription-polymerase chain reaction, lentiviral vectors, cell counting and myelination quantification are described in the online Supplementary Material.
Results
The human foetal forebrain undergoes a switch from neurogenesis to oligodendrogenesis during the first trimester of gestation Sections of 7.5-week-old foetuses were used to characterize the various cell types present in the human forebrain by immunohistochemistry ( Fig. 1; Supplementary Fig. 1 ). At this stage of development, the vast majority of cells expressed Nestin ( Supplementary Fig. 1D-F) , a marker of neuroepithelial cells and early progenitors, indicating the immaturity of the forebrain.
Most Nestin + cells co-expressed MAP5 ( Supplementary Fig. 1D-F) and b3-tubulin, two neuroblast markers, indicating that the forebrain was undergoing neurogenesis. Astrocytes were not detected in either the telencephalon or diencephalon, as revealed by the absence of GFAP immunoreactivity in these regions. In the telencephalon, Olig2 + cells were concentrated in the ventricular and subventricular zones of medial ganglionic eminences (Supplementary Fig. 1E ; Fig. 1A , B and F) and entopeduncular area (Fig. 1A , B and G), and to a lesser extent in lateral ganglionic eminences ( Fig. 1A and B ), but none were detected in the cortex (Supplementary Fig. 1D ; Fig. 1A , B and E). Olig2 + cells were also found in the diencephalon, in the thalamus and hypothalamus (Supplementary Fig. 1F ; Fig analysis of Olig2 expression pattern performed on forebrain sections of 7.5 week-old foetuses at the telencephalic (A-B and E-G) and diencephalic (C-D, H) levels. While Olig2 was absent from cortex (E, red), it was massively expressed in medial ganglionic eminences (F, red), entopeduncular area (G, green) and to a lesser extent in thalamus (H, red) and hypothalamus (D, red). (I-S) Double immunohistochemical staining against Olig2 (green) and the oligodendrocyte progenitor cell-specific markers Sox10 (I-P) and platelet derived growth factor receptor a (Q-S), showing the emergence of the first oligodendrocyte progenitor cells in the subventricular zone of medial ganglionic eminences (I-L) and entopeduncular area (M-S). (T) Semi-quantitative reverse transcription-polymerase chain reaction performed on snap-frozen tissue from cortex, ganglionic eminences (GE) and thalamus. Nestin and neuron-specific enolase expression in the three regions, as well as GFAP absence of expression, confirmed that the foetal forebrain was undergoing neurogenesis. Although expressed in the three regions, Olig2 and Sox10 transcripts were prominent in ganglionic eminences. PDGF-Ra = platelet derived growth factor receptor alpha; CGE = caudal ganglionic eminences; Cx = cortex; EPA = entopeduncular area; HyThal = hypothalamus; LGE = lateral ganglionic eminences; MGE = medial ganglionic eminences; SVZ = subventricular zone; Thal = thalamus; VZ = ventricular zone. Scale bars: (A-D) 1 mm; (E-H) 200 mm; (I and M) 100 mm; (J, N and Q) 10 mm.
indicating their neuroblastic phenotype, a few Olig2 + cells co-expressed the transcription factor Sox10 ( Fig. 1I -P) and platelet derived growth factor receptor a ( Fig. 1Q -S) in medial ganglionic eminences and entopeduncular area, which identified them as oligodendrocyte progenitor cells. The extremely small number (50.01%) of these cells, which were found only in these regions and only outside the ventricular zone, combined with the fact that late oligodendrocyte progenitor cell markers such as NG2 and O4 were not expressed, indicated that oligodendrogenesis was at its very beginning. Thus, although the human forebrain was undergoing neurogenesis, our data highlight that oligodendrocyte progenitor cell specification onsets in the ventral telencephalon as early as 7.5 weeks of gestation. The phenotype of the forebrain cells was also characterized by reverse transcription-polymerase chain reaction performed on RNA extracts from cortex, ganglionic eminences and thalamus tissue (Fig. 1T ). Nestin and neuron-specific enolase transcripts were expressed in the three regions, confirming the presence of neuroepithelial cells and neuroblasts, and GFAP transcripts were not expressed, consistent with the immunohistochemical analysis. Interestingly, Olig2 and Sox10 transcripts were present in the three regions, whereas the proteins were expressed only in ventral telencephalon. However, consistent with the high expression of Olig2 protein in ganglionic eminences, semi-quantitative analysis indicated that Olig2 transcripts were expressed at a much higher level ($14-fold) in ganglionic eminences than in cortex and thalamus.
Phenotypic characteristics of cortex, ganglionic eminences and thalamus cells are maintained in vitro after isolation from the human foetal forebrain
The phenotype of hNPCs from the various regions was further characterized by RT-polymerase chain reaction and immunocytochemistry on dissociated cells from cortex, ganglionic eminences and thalamus. After 5 days in vitro, hNPCs from the three regions mainly consisted of Nestin + neuroepithelial-like cells (47.3 AE 0.9, 51.6 AE 1.1 and 22.4 AE 2.1% in cortex, ganglionic eminences and thalamus, respectively) ( 2K) . Therefore, the majority of A2B5 + cells from cortex and thalamus corresponded to neuroblasts, whereas A2B5 + cells from ganglionic eminences mainly corresponded to glial progenitors. Reverse transcription-polymerase chain reaction analysis of freshly dissociated cells (Fig. 2L ) correlated with the in vitro data, with Nestin and neuron-specific enolase, but not GFAP (not shown), expressed in the three regions. Noticeably, transcripts of the oligodendroglial lineage, such as Olig2, Olig1 and Sox10, were detected in ganglionic eminences and thalamus, whereas they were expressed at very low (Sox10) or even undetectable Table 1 In vitro characterization of hNPC phenotype after short-and long-term culture (Olig1/2) levels in cortex. Semi-quantitative analysis of gene expression indicated that neuron-specific enolase was expressed at higher levels ($2-fold) in thalamus than in cortex and ganglionic eminences. Moreover, Olig2 expression was about 2.6-fold higher in ganglionic eminences than in thalamus, and Sox10 expression was about 4.3-fold higher in ganglionic eminences than in cortex and about 1.5-fold higher in ganglionic eminences than in thalamus, stressing that putative early oligodendrocyte progenitor cells were concentrated in ganglionic eminences.
Long-term amplification in vitro enhances the proportion of immature neural cells
In order to obtain large-scale cultures for cell transplantation, primary cultures of hNPCs were initiated from the three regions. Consistent with their more mature initial phenotype, hNPCs from thalamus grew slower than hNPCs from cortex and ganglionic eminences, with fewer and smaller spheres being generated at each passage, and some adherent cells appearing in the flasks (not shown). However, cells from the three regions could be maintained and amplified in vitro for at least 100 days. By that time, 36.7 AE 1.0, 42.6 AE 1.2 and 24.5 AE 0.8% of the cells expressed Ki67 in cortex, ganglionic eminences and thalamus, respectively (Table1; Supplementary Fig. 3A -C) and the vast majority of cells from the three regions expressed Nestin (98.2 AE 0.1, 98.5 AE 0.1 and 97.7 AE 0.3% in cortex, ganglionic eminences and thalamus, respectively) ( Table 1 ; Supplementary Fig. 3A-C) . A proportion of cells expressed GFAP (22.3 AE 0.9, 5.6 AE 0.5 and 14.7 AE 1.0% in cortex, ganglionic eminences and thalamus, respectively) ( Table 1 ; Supplementary Fig. 3D-F) . Virtually all GFAP + cells expressed Nestin (not shown), indicating that a fraction of the Nestin + cells corresponded to astrocytes. However, the Nestin + /GFAP À fraction, which corresponded to immature neuroepithelial-like cells, represented a large majority (75.9, 92.9 and 83.0% in cortex, ganglionic eminences and thalamus, respectively). After amplification in vitro, the proportions of neuroblasts were considerably decreased (2.8 AE 0.3, 2.1 AE 0.1 and 3.7 AE 0.3% of b3-tubulin + cells in cortex, ganglionic eminences and thalamus, respectively) (Table1; Supplementary Fig. 3D-F ) and O4 + oligodendrocytes were no longer detected. As compared with short-term characterization, the proportion of A2B5 + cells in long-term cultures was decreased by 5.9-and 16.2-fold in cortex and thalamus, respectively (with 0.9 AE 0.1 and 1.2 AE 1.1% of A2B5 + cells, respectively), whereas it was maintained in ganglionic eminences (with 3.4 AE 0.2% of A2B5 + cells) (Table1; Supplementary Fig. 3G-I ). Finally, Olig2 expression was unchanged in ganglionic eminences (29.1 AE 1.0%), whereas it was upregulated in cortex (24.9 AE 1.3%) and thalamus Human foetal neural progenitor cells display long-term survival and widespread migration after transplantation into demyelinated spinal cord
In vivo approaches were then used to assess the remyelinating abilities of hNPCs from the three forebrain regions. After amplification in vitro, cells from cortex, ganglionic eminences and thalamus were transduced with a lentiviral vector encoding GFP. The proportions of GFP + cells were 92.8 AE 0.8, 85.3 AE 2.6 and 95.6 AE 0.6% of the total hNPCs in cortex, ganglionic eminences and thalamus, respectively, indicating very high transduction efficiency ( Supplementary Fig. 4) . Transduced cells were then transplanted into the demyelinated adult nude mouse spinal cord and animals were sacrificed 6 and 33-49 weeks later for shortand long-term analysis of hNPC fate in vivo. Human GFP + cells were found in all transplanted animals at all time points, indicating that they survived in the host environment for almost 1 year. At 6 weeks post-grafting, proliferation was considerably reduced, as estimated by the proportion of Ki67 + cells among the GFP + cell population (0.4 AE 0.3, 0.8 AE 0.4 and 2.3 AE 0.7% in cortex, ganglionic eminences and thalamus, respectively), and had completely stopped by 33-49 weeks post-grafting. Interestingly, grafted hNPCs from the three regions displayed a high migratory potential within the mouse spinal cord (Figs 3  and 4) . At 6 weeks post-grafting, GFP + cells had already consistently migrated from the injection site (estimated distance of migration: 6.5 AE 1.1, 6.8 AE 0.7 and 6.3 AE 0.8 mm in cortex, ganglionic eminences and thalamus groups, respectively) (Figs 3A and 4A) and continued progressing both caudally and rostrally up to 33-49 weeks post-grafting, reaching strikingly long distances from the injection site (26.0 AE 1.8, 25.3 AE 2.8 and 22.6 AE 0.5 mm between the most rostral and the most caudal GFP + cells in cortex, ganglionic eminences and thalamus groups, respectively) ( Fig. 3A and B, Supplementary Fig. 5B and C) . Moreover, at 6 weeks postgrafting, GFP + cells were located almost exclusively within the dorsal funiculus (Fig. 4A ) whereas, at 33-49 weeks post-grafting, they had also migrated ventrally, preferentially reaching ventral white matter (Figs 3C-E and 4B) and occasionally grey matter (Figs 3D, E, 4B and C). Thus, a single injection point allowed considerable colonization of the spinal cord by the grafted hNPCs. Most interestingly, although the total distance of migration was similar among the three groups, cell dispersal did not occur according to the same pattern in cortex, ganglionic eminences and thalamus. The evaluation of human cell density, expressed as a function of the distance from the injection site (Fig. 4D-F) , revealed that, at 6 weeks post-grafting, human cells from ganglionic eminences dispersed more efficiently than cells from cortex and thalamus (blue curves in Fig. 4D-F) . At 33-49 weeks post-grafting (pink curves in Fig. 4D-F) , cells from cortex and ganglionic eminences ( Fig. 4D and E) were no longer concentrated around the injection site and displayed equivalent distribution. In contrast, cells from thalamus ( Fig. 4F) remained concentrated around the injection site and displayed poorer dispersal. In addition, at both 6 and 33-49 weeks post-grafting, cells from thalamus (Fig. 4F ) displayed poorer survival than cells from cortex ( Fig. 4D ) and ganglionic eminences (Fig. 4E) . Thus, it appears that, after long-term amplification in vitro, hNPCs from the three regions retained some properties related to their territorial origins that might have influenced their migration potential in vivo.
Human foetal neural progenitor cells give rise to differentiated oligodendrocytes after grafting into demyelinated spinal cord
We then evaluated the ability of hNPCs to differentiate into the three main neural lineages. Astroglial differentiation of hNPCs was revealed by the consistent expression of human-specific GFAP (SMI21) in every group ( Fig. 5A and D) at both 6 weeks post-grafting (27.5 AE 4.1, 30.0 AE 3.3 and 37.4 AE 3.2% in cortex, ganglionic eminences and thalamus groups, respectively) and 33-49 weeks post-grafting (28.9 AE 2.2, 29.0 AE 2.2 and 38.4 AE 3.8% in cortex, ganglionic eminences and thalamus groups, respectively). Neuronal differentiation was assessed by anti-MAP2, anti-NeuN and anti-human Tau immunostaining. MAP2 was not detected at 6 weeks post-grafting (Fig. 5E ), but was expressed by a few GFP + human cells at 33-49 weeks post-grafting (0.5 AE 0.2, 0.7 AE 0.4 and 0.4 AE 0.2% in cortex, ganglionic eminences and thalamus groups, respectively) ( Fig. 5B and E) , indicating that, after grafting into the demyelinated white matter, hNPCs differentiated into neurons to an extremely limited extent. This was further suggested by the absence of NeuN staining at both time points tested. Numerous Tau + cells were nevertheless observed at 6 and 33-49 weeks post-grafting (Fig. 6F) . While Tau immunoreactivity may reveal the presence of either neuronal or oligodendroglial cells (LoPresti et al., 1995; LoPresti, 2002) , the absence of NeuN staining, the small number of MAP2 + /GFP + cells and the multipolar morphology of Tau + cells (Fig. 6F ) suggested that the vast majority of the latter were in fact oligodendrocytes. The ability of hNPCs to differentiate into mature oligodendrocytes in vivo was confirmed with other oligodendroglial markers. At 6 weeks post-grafting, APC(CC1) was expressed by 11.4 AE 2.4, 13.3 AE 2.3 and 14.9 AE 3.8% of GFP + cells in cortex, ganglionic eminences and thalamus groups, respectively, without any significant differences among the three groups (Fig. 5F ). At 33-49 weeks post-grafting, the percentage of GFP + cells expressing APC(CC1) (Figs 5C and 6A) increased nearly 4-fold and reached 39.5 AE 2.9, 37.1 AE 2.5 and 41.1 AE 2.5% in cortex, ganglionic eminences and thalamus groups, respectively (Fig. 5F ). Human NOGO-A (Fig. 6B) , Olig2 (Fig. 6D) and Sox10 (Fig. 6E) were also expressed among the GFP + cell populations. Moreover, some multipolar GFP + cells extended long processes that enwrapped axons, expressed MBP and formed node of Ranvier-like structures (Fig. 6C) , thereby strongly suggesting that at least some of the differentiated oligodendrocytes could form myelin.
Human neural progenitor cells from cortex, ganglionic eminences and thalamus form compact myelin in adult 'shiverer' mouse spinal cord Cytoplasmic GFP is generally excluded from compact myelin, thus rendering remyelination by exogenous cells difficult to appreciate in wild-type animals. Human NPCs from cortex, ganglionic eminences and thalamus were therefore grafted into the focally demyelinated spinal cord of adult 'shiverer' mice that lack MBP expression and display uncompacted myelin at the ultrastructural level, thus allowing detection of donor-derived oligodendrocytes. Animals were sacrificed as late as possible given their lifespan (at 10.5 weeks post-grafting) and used for both immunohistochemical and ultrastructural analysis. Consistent expression of MBP ( Fig. 7B-J) and human NOGO-A (Fig. 7F-H) confirmed the ability of hNPCs to give rise to myelinating oligodendrocytes. Interestingly, the MBP expression pattern indicated that, as in nude mice, human cells migrated over long distances (up to 8.5 mm) along the rostro-caudal axis ( Fig. 7A and B) and were not only present in the dorsal funiculus (Fig. 7B, C and F) , but also in the ventral white matter (Fig. 7B and D) and less frequently in the grey matter ( Fig. 7E and G) . The extent of hNPC-derived myelination was assessed on coronal spinal cord sections by estimating the ratio of MBP + area on MOG + white matter area at different rostro-caudal levels (Fig. 7A ). This measurement showed that up to 8.1 AE 0.7% of the white matter could be myelinated by human cells at the injection level. Confocal analysis showed that NOGO-A + cells extended multipolar processes that enwrapped NF + axons (Fig. 7F and G) , formed MBP + internodes (Fig. 7G-J) and typical node of Ranvier-like structures (Fig. 7H) . Most interestingly, the clustering of Caspr at the paranodes ( Fig. 7I and J) and of Na v channels at the nodes of Ranvier (Fig. 7J) further suggested the functionality of donor-derived myelin. Animals were also used for ultrastructural analysis of myelin compaction. In control 'shiverer' mice that received neither lysolecithin injection nor graft (Fig. 8A-C) , as well as in animals that received lysolecithin injection but no graft (Fig. 8D-F) , the vast majority of axons were either non-myelinated ( Fig. 8B and E) or enwrapped with loose myelin displaying large cytoplasmic (Fig. 8C and F) and compact myelin sheaths were not observed. In animals that received both lysolecithin injection and hNPC graft (Fig. 8G-K) , normal myelin sheaths with alternate major dense lines and intermediate lines (Fig. 8J-K) were observed, thus demonstrating unambiguously that hNPCs from foetal cortex, ganglionic eminences and thalamus differentiated into mature oligodendrocytes with the ability to form compact myelin around host axons.
Discussion
In the present study, we combined in situ, in vitro and in vivo studies to highlight the oligodendrogenic potential of different human foetal forebrain regions. We showed for the first time that the initial wave of oligodendrocyte progenitor cell emergence onsets as early as 7.5 weeks of gestation in the ventral telencephalon. Compartmentalization of the forebrain during that early window of development allowed consistent enrichment in putative oligodendrocyte progenitor cells in vitro after isolation of ganglionic eminences, as compared with cortex and thalamus. Finally, transplantation of hNPCs into two different models of focal gliotoxic demyelination demonstrated the great potential of cells isolated from these three regions to survive, migrate and successfully remyelinate the adult spinal cord.
Developmental biology has been widely used to understand normal and pathological oligodendrogenesis in the rodent CNS (Woodruff et al., 2001; Peru et al., 2006; Costa et al., 2009) . Despite the scarcity of human embryonic and foetal tissue, ongoing efforts to understand human CNS development have allowed the establishment of many inter-species highly conserved mechanisms between human and rodent oligodendrogenesis (Hajihosseini et al., 1996; Grever et al., 1997; Back et al., 2001; Rakic and Zecevic, 2003; Chandran et al., 2004; Jakovcevski and Zecevic, 2005a, b) . However, until now, the majority of data describing human oligodendrocyte development within the telencephalon were obtained from second trimester foetuses, at a time by which oligodendroglial cells had already spread within ventral and dorsal forebrain parenchyma (Rakic and Zecevic, 2003; Jakovcevski and Zecevic, 2005a, b) . The paucity of earlier foetal tissue led to the erroneous idea that oligodendrocyte progenitor cell emergence might have larger sites of origin in human (the whole telencephalic ventricular zone) than in rodent forebrain (Jakovcevski and Zecevic, 2005b) . Here, using earlier foetal brain tissue, we demonstrate for the first time that oligodendrocyte progenitor cell emergence onsets earlier than previously thought, after $7.5 weeks of gestation. By that time, not only did the pattern of Olig2 expression closely resemble the one displayed by rodent CNS at embryonic Day 12.5 (Ligon et al., 2004; Rowitch, 2004; Richardson et al., 2006) but, in some cells emerging out of the ventricular zone, Olig2 expression was accompanied by Sox10 and platelet derived growth factor receptor a expression, indicating their belonging to the oligodendroglial lineage. As in rodents, oligodendrocyte progenitor cell emergence was restricted to medial ganglionic eminences and entopeduncular area, thus allowing the establishment of a close parallel between 7.5-week-old human foetuses and embryonic Day 12.5 rodent embryos in terms of oligodendrocyte lineage development. Consistent with our in situ study, immunocytochemical and reverse transcription-polymerase chain reaction analysis performed on forebrain dissociated cells indicated that Olig2 expression was prominent in ganglionic eminences. Moreover, the majority of A2B5 + cells were identified as MAP5 + neuroblasts in cortex and thalamus, whereas they mostly corresponded to early MAP5 À glial progenitors in ganglionic eminences. This indicates that the isolation of a specific brain region allowed enrichment of a specific cell type and that such a CNS compartmentalization may be of potential benefit for oligodendroglial differentiation and myelin repair. While necessary for the achievement of large-scale cultures, long-term in vitro amplification nevertheless induced major changes in the phenotypes of cells from the three regions. The most noticeable included: (i) an increase in Olig2 expression in cortex and thalamus groups, two dorsal regions where Olig2 was barely detectable in vitro at the time of explantation; (ii) a significant decrease in neuroblast proportions in the three groups; and (iii) a large increase in immature Nestin + /GFAP À cell proportions. Moreover, consistent with previous studies (Roy et al., 1999; Zhang et al., 2000; Chandran et al., 2004) , spontaneous generation of oligodendrocytes was not observed in any of the three groups. Most of these observations may be related to the effects of basic fibroblast growth factor, which has been widely used, alone or in combination with epidermal growth factor, for NPC amplification (Buc-Caron, 1995; Svendsen et al., 1998; Carpenter et al., 1999; Palmer et al., 2001; Buchet et al., 2002b) . Indeed, it has been shown that basic fibroblast growth factor deregulates dorso-ventral patterning of embryonic rodent spinal cord progenitors (Gabay et al., 2003) in part by inducing Olig2 expression in dorsal progenitors. Moreover, basic fibroblast growth factor exposure induces Olig2 expression in human embryonic stem cell-derived NPCs (Hu et al., 2009) but prevents these cells from differentiating into motoneurons. Finally, basic fibroblast growth factor represses the transition between the Olig2 + pre-oligodendrocyte progenitor cell stage towards the oligodendrocyte progenitor cell stage by disrupting Shh-dependent co-expression of Olig2 and Nkx2.2 (Hu et al., 2009) , thereby explaining the scarcity of oligodendrocyte progenitor cells and mature oligodendrocytes in foetal hNPC cultures (Roy et al., 1999; Zhang et al., 2000; Chandran et al., 2004) . Thus, neuroepithelial cell selection, attended by deregulation of Olig2 expression, inhibition of neuroblast commitment and inhibition of pre-oligodendrocyte progenitor cell to oligodendrocyte progenitor cell stage transition, might have induced enrichment in preoligodendrocyte progenitor cells in our cultures. This enrichment in immature Olig2 + cells may be, at least in part, responsible for the fact that these cells generated large numbers of mature oligodendrocytes after grafting, irrespective of their territorial origins and despite their amplification in vitro. Two demyelination paradigms were used to assess the remyelinating abilities of hNPCs from each region in vivo. After grafting into the demyelinated spinal cord of adult nude mice, hNPCs from cortex, ganglionic eminences and thalamus survived almost 1 year, by which time they had completely stopped proliferating. Most importantly, tumour formation was not observed at any time point after grafting. The limited lifespan of 'shiverer' mice did not allow such a long-term analysis, but this second model was conclusively used to attest for newly formed myelin compaction. Remarkably, in both models, a single injection point was sufficient for extensive migration of the grafted hNPCs throughout the adult spinal cord white matter, and this migration occurred in both a rostro-caudal and dorso-ventral manner. Widespread migration with eventual chimerization of host rodent CNS was reported when foetal hNPCs/glial progenitors were grafted into the embryonic (Brustle et al., 1998) or newborn brain (Gumpel et al., 1987; Flax et al., 1998; Windrem et al., 2008) , thereby allowing donor cells to benefit from guidance cues present in the developing CNS. Nonetheless, entire colonization of the host tissue required large entry routes, such as the ventricular system (Brustle et al., 1998; Flax et al., 1998) , or multiple injection sites , as well as large numbers of donor cells (Brustle et al., 1998; Windrem et al., 2008) . On the contrary, when foetal hNPCs (Fricker et al., 1999) or adult human glial progenitor cells (Windrem et al., 2002) were focally injected into the adult parenchyma, they generally displayed more limited migration. Surprisingly, in our study, a single focal injection of a limited number of cells was sufficient to allow long-distance migration of the hNPCs, despite the less permissive adult environment. This striking ability of early foetal hNPCs to colonize the host adult CNS is probably related to both the immaturity of the donor cells and their intrinsic differentiation tempo. Previous studies have demonstrated that human foetal glial progenitors display a greater migratory potential and slower differentiation when isolated from late gestation foetal tissue than from the adult brain (Windrem et al., 2004) . This study, therefore, suggested that the earlier the human glial progenitors were obtained, the greater their migratory potential was, even though they were isolated according to the same criteria and with the same technique. Here, hNPCs were isolated at a very early stage of development and amplified in vitro, a process that reinforced the immaturity of the donor cells. Moreover, the temporal increase in donor-derived APC(CC1) + mature oligodendrocytes and, to a lesser extent, of MAP2 + neurons after grafting indicated that hNPC differentiation was a slow process. Consistent with this observation, in vitro studies showed that human embryonic stem cells display a much longer differentiation process than their rodent counterparts (Izrael et al., 2007; Hu et al., 2009) . Thus, the great immaturity of the cells at the time of grafting, as well as their species-related slow differentiation, may account for their extensive migratory potential. In addition, this potential was not lowered by donor-derived astrocytes, which never appeared to form a glial scar. Our study, therefore, provides a paradigm by which the number of injection points can be limited and holds great promise for the treatment of CNS pathologies where donor cell migration is required. The extensive migration of the hNPCs within the host parenchyma indicates that grafted cells did not specifically target the focally demyelinated area. Nevertheless, despite the absence of demyelinating cues outside the lesion, human cells actually produced myelin at long distances from their injection site, in both nude and 'shiverer' mice. In 'shiverer' mice, endogenous dysmyelination and altered oligodendrocyte-neuron interactions may account for the ability of the donor cells to replace endogenous oligodendrocytes. This has also been suggested by Windrem et al. (2008) , who virtually induced 'humanization' of the 'shiverer' brain by transplanting second trimester foetal human glial progenitor cells in neonates. In their study, the authors discuss the possibility that human cells display a competitive strength over endogenous progenitors during post-natal development. Here, the fact that hNPCs were grafted into the adult spinal cord more likely implies replacement of the host deficient oligodendrocytes rather than competition with endogenous progenitors. It is possible that the grafted hNPCs took advantage of the increasing number of demyelinated axons in the ageing adult 'shiverer' CNS. Furthermore, we cannot rule out the possibility that hNPCs displayed an 'aggressive' behaviour towards host oligodendrocytes and then myelinated the axons they had themselves contributed to demyelinate. Either way, although post-natal 'shiverer' mice have been widely used as a paradigm to assess myelinating abilities of various cell types (Gumpel et al., 1987; Yandava et al., 1999; Nistor et al., 2005; Izrael et al., 2007; Windrem et al., 2008) , very few studies documented these features in the adult 'shiverer' CNS, at a time by which the pathology has already settled (Cummings et al., 2005; Eftekharpour et al., 2007) . Moreover, neither the extent of remyelination nor the migration achieved by the grafted cells were evaluated. Here, we show that NPCs of human origin are able to migrate extensively and produce myelin outside the temporal window of post-natal myelination, when developmental cues are no longer present, thereby offering the hope that genetic diseases with long-term molecular abnormalities, such as leucodystrophies, can be successfully reversed after the establishment of the pathology.
The situation in nude mice is more puzzling. Whether hNPCs myelinate unmyelinated axons of the spinal cord or replace formerly existing, healthy oligodendrocytes is unclear. It is now well-established that the adult parenchyma contains proliferating glial progenitors (Nishiyama et al., 2009 ) that participate in remyelination when demyelination occurs (Franklin and ffrenchConstant, 2008) . Under normal conditions, the majority of these proliferating cells eventually die, while some ($5%) give rise to mature oligodendrocytes (Horner et al., 2000) , thereby pleading in favour of a natural, albeit slow, turnover of myelinating oligodendrocytes in the adult CNS (Lasiene et al., 2009) . In the present study, it is likely that hNPCs participated in this turnover in the mouse CNS. However, the existence of such a process remains a subject of debate, since myelinating oligodendrocyte replacement would imply a transitional 'nakedness' of axons.
Altogether, our data provide a link between developmental biology and experimental cell therapy, and reveal that early foetal hNPCs may offer new hope for the treatment of myelin affections. Although the functional equivalence of oligodendrocytes emerging from different CNS regions during development remains an open issue , we show that hNPCs isolated from different forebrain areas can replace oligodendrocytes lost in demyelinating diseases with equal efficiency. Recently, oligodendrocyte progenitor cell derivation has been achieved from novel, virtually unlimited cell sources, such as human embryonic stem cells (Izrael et al., 2007; Hu et al., 2009 ) and induced pluripotent stem cells (Hu et al., 2010) . However, as tissue-derived stem/progenitor cells, foetal hNPCs present the clear advantage over pluripotent cells to be 'neurally committed' and to lack hNPCs remyelinate the mouse spinal cord http://brain.oxfordjournals.org/ tumourigenicity after grafting. Hence, to date, foetal hNPCs still represent one of the safest means to achieve cell replacement in CNS diseases, and going thoroughly into the knowledge of their biological properties remains one of the key issues for efficient cell therapy of myelin affections. The present study provides a paradigm by which foetal hNPCs can be amplified in vitro, thereby giving rise to large-scale donor cells, before achieving extensive remyelination of the CNS without the need of oligodendrocyte progenitor cell selection or multiple injections. Therefore, our work sheds some new light on early oligodendrogenesis in the human forebrain and puts forward early foetal hNPCs as an efficient tool to carry out successful remyelination of the adult CNS.
